1. Home
  2. CALC vs LOCL Comparison

CALC vs LOCL Comparison

Compare CALC & LOCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CalciMedica Inc.

CALC

CalciMedica Inc.

HOLD

Current Price

$0.66

Market Cap

19.1M

Sector

Health Care

ML Signal

HOLD

Logo Local Bounti Corporation

LOCL

Local Bounti Corporation

N/A

Current Price

$1.06

Market Cap

22.8M

ML Signal

N/A

Company Overview

Basic Information
Metric
CALC
LOCL
Founded
2011
2021
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Farming/Seeds/Milling
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
19.1M
22.8M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
CALC
LOCL
Price
$0.66
$1.06
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$10.00
N/A
AVG Volume (30 Days)
283.8K
18.8K
Earning Date
05-13-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
60.33
EPS
N/A
N/A
Revenue
N/A
$48,365,000.00
Revenue This Year
N/A
$97.19
Revenue Next Year
N/A
$33.69
P/E Ratio
N/A
N/A
Revenue Growth
N/A
26.82
52 Week Low
$0.46
$0.95
52 Week High
$7.20
$4.00

Technical Indicators

Market Signals
Indicator
CALC
LOCL
Relative Strength Index (RSI) 45.59 47.06
Support Level $0.52 $0.98
Resistance Level $0.77 $1.22
Average True Range (ATR) 0.08 0.09
MACD -0.01 0.02
Stochastic Oscillator 17.08 44.96

Price Performance

Historical Comparison
CALC
LOCL

About CALC CalciMedica Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys. The company operates as one operating segment focused on developing and commercializing therapeutics in the U.S.

About LOCL Local Bounti Corporation

Local Bounti Corp is a controlled environment agriculture company. The business model is based on building local facilities, operated by local teams, to deliver fresh and quality produce to local communities while maintaining a limited carbon footprint. Using proprietary technology to grow leafy greens and herbs in smart greenhouses with a cultivation process that uses less water and land than conventional agriculture, free from herbicides or pesticides. The products of the company include living lettuce, leafy greens, herbs, and others.

Share on Social Networks: